RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,136,494 | +17.9% | 135,136 | +76.1% | 0.00% | 0.0% |
| Q2 2023 | $963,666 | -42.7% | 76,725 | -24.9% | 0.00% | -50.0% |
| Q1 2023 | $1,682,838 | +10.2% | 102,176 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,526,509 | -31.0% | 102,176 | +3.2% | 0.00% | -33.3% |
| Q3 2022 | $2,213,779 | +359.3% | 98,962 | +244.0% | 0.00% | +200.0% |
| Q2 2022 | $482,000 | -39.5% | 28,772 | +8.1% | 0.00% | -50.0% |
| Q1 2022 | $797,000 | +4.7% | 26,620 | +7.4% | 0.00% | +100.0% |
| Q4 2021 | $761,000 | +5.3% | 24,787 | +8.1% | 0.00% | 0.0% |
| Q3 2021 | $723,000 | -13.8% | 22,921 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $839,000 | +22.3% | 22,921 | +15.5% | 0.00% | +100.0% |
| Q1 2021 | $686,000 | +17.9% | 19,845 | +41.8% | 0.00% | 0.0% |
| Q4 2020 | $582,000 | +33.8% | 13,996 | +37.0% | 0.00% | 0.0% |
| Q3 2020 | $435,000 | – | 10,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Grace Capital | 183,112 | $5,665,000 | 3.48% |
| Casdin Capital, LLC | 3,668,574 | $115,670,000 | 2.88% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $879,843,000 | 2.73% |
| BVF INC/IL | 2,049,113 | $64,609,000 | 2.52% |
| Fernwood Investment Management, LLC | 185,063 | $5,835,000 | 2.00% |
| EcoR1 Capital, LLC | 1,385,276 | $43,678,000 | 1.52% |
| Boxer Capital, LLC | 1,294,132 | $40,804,000 | 1.42% |
| Integral Health Asset Management, LLC | 140,000 | $4,414,000 | 1.27% |
| Alphabet Inc. | 1,641,497 | $51,756,000 | 1.23% |
| Bellevue Group AG | 3,755,962 | $118,426,000 | 1.20% |